US Patent

US8808716 — Topical foam composition

Formulation · Assigned to Stiefel Research Australia Pty Ltd · Expires 2030-02-24 · 4y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a novel oil-in-water emulsion aerosol foam composition containing an active agent for treating skin conditions like acne and psoriasis.

USPTO Abstract

The present invention relates to a novel oil in water emulsion aerosol foam composition containing an active agent for the treatment of various chronic and acute skin conditions, particularly acne and psoriasis; and processes for preparing the emulsion aerosol foam compositions. In particular, the present invention relates to oil in water emulsion aerosol foam compositions containing a retinoid in the oil phase.

Drugs covered by this patent

Patent Metadata

Patent number: US8808716
Jurisdiction: US
Classification: Formulation
Expires: 2030-02-24
Drug substance claim: No
Drug product claim: Yes
Assignee: Stiefel Research Australia Pty Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.